Expansion of range of joint motion following treatment of systemic sclerosis with tocilizumab

Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis

(2012) Korsa Khan et al.   ANNALS OF THE RHEUMATIC DISEASES

A Prospective Observational Study of Mycophenolate Mofetil Treatment in Progressive Diffuse Cutaneous Systemic Sclerosis of Recent Onset

(2012) F. A. MENDOZA et al.   JOURNAL OF RHEUMATOLOGY

Effect of bosentan on skin fibrosis in patients with systemic sclerosis: a prospective, open-label, non-comparative trial

(2010) A. Kuhn et al.   RHEUMATOLOGY

The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab

(2010) Y. Shima et al.   RHEUMATOLOGY

EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)

(2009) O Kowal-Bielecka et al.   ANNALS OF THE RHEUMATIC DISEASES

An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis

(2008) C P Denton et al.   ANNALS OF THE RHEUMATIC DISEASES